Non-viral ex vivo genome-editing in mouse bona fide hematopoietic stem cells with CRISPR/Cas9

We conducted two lines of genome-editing experiments of mouse hematopoietic stem cells (HSCs) with the clustered regularly interspaced short palindromic repeat (CRISPR) and CRISPR-associated protein 9 (Cas9). First, to evaluate the genome-editing efficiency in mouse bona fide HSCs, we knocked out in...

Descripción completa

Detalles Bibliográficos
Autores principales: Byambaa, Suvd, Uosaki, Hideki, Ohmori, Tsukasa, Hara, Hiromasa, Endo, Hitoshi, Nureki, Osamu, Hanazono, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873578/
https://www.ncbi.nlm.nih.gov/pubmed/33614821
http://dx.doi.org/10.1016/j.omtm.2021.01.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873578/
https://www.ncbi.nlm.nih.gov/pubmed/33614821
http://dx.doi.org/10.1016/j.omtm.2021.01.001

Ejemplares similares